A patient taking St. John's Wort to manage depression should be educated about which crucial safety issue?

A. It is always a safer option than anti-depressants: Labeling an herbal supplement as "safer" is scientifically inaccurate as they are not regulated with the same rigor as pharmaceuticals. St. John's Wort carries significant risks and side effects that can be as severe as conventional medications. Natural origin does not equate to absence of pharmacological danger. B. It can cause dependency and addiction: St. John's Wort is not associated with the neurobiological pathways that lead to physical dependence or addictive behaviors. While it affects neurotransmitter levels, it does not share the addictive profile of substances like opioids or benzodiazepines. This is not a primary safety concern for this supplement. C. It needs to be taken in large doses to be effective: High doses of St. John's Wort increase the risk of photosensitivity and serotonin syndrome without necessarily improving therapeutic outcomes. Effective dosing must be carefully balanced to avoid toxicity while attempting to achieve a mood-stabilizing effect. Dose escalation should only occur under medical supervision. D. It can significantly interfere with the metabolism of prescription medications: This herb is a potent inducer of the Cytochrome P450 enzyme system, specifically the CYP3A4 isoenzyme. This increases the clearance of many drugs, including anticoagulants, oral contraceptives, and antiretrovirals, rendering them ineffective. This represents a major clinical safety risk for patients.